Halozyme Therapeutics, Inc.

HALO · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$115,850$118,370$234,195$118,719
Short-Term Investments$480,224$217,630$128,599$622,203
Receivables$308,455$234,210$231,072$90,975
Inventory$141,860$127,601$100,123$53,908
Other Curr. Assets$38,951$48,613$45,024$40,482
Total Curr. Assets$1,085,340$746,424$739,013$926,287
Property Plant & Equip (Net)$75,035$74,944$75,570$8,794
Goodwill$416,821$416,821$409,049$0
Intangibles$401,830$472,879$546,652$0
Long-Term Investments$0$0$0$0
Tax Assets$3,855$4,386$44,426$155,434
Other NC Assets$80,596$17,816$26,801$13,914
Total NC Assets$978,137$986,846$1,102,498$178,142
Other Assets$0$0$0$0
Total Assets$2,063,477$1,733,270$1,841,511$1,104,429
Liabilities
Payables$10,249$11,816$17,693$1,541
Short-Term Debt$0$0$13,334$89,419
Tax Payable$0$963$0$0
Deferred Revenue$0$0$3,246$1,746
Other Curr. Liab.$128,851$99,715$96,516$24,441
Total Curr. Liab.$139,100$112,494$130,789$117,147
LT Debt$1,505,798$1,499,248$1,492,766$787,255
Deferred Rev, NC$0$0$2,253$2,530
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$54,758$37,720$45,905$544
Total NC Liab.$1,560,556$1,536,968$1,540,924$790,329
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$1,699,656$1,649,462$1,671,713$907,476
Equity
Pref Stock$0$0$0$0
Common Stock$123$127$135$138
Retained Earnings$359,869$90,550$143,217-$58,912
AOCI$3,829-$9,278-$922-$620
Other Equity$0$2,409$27,368$256,347
Total Equity$363,821$83,808$169,798$196,953
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$2,063,477$1,733,270$1,841,511$1,104,429
Net Debt$1,389,948$1,380,878$1,271,905$757,955